Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 389,992 | 360,071 | 388,647 | 370,232 | 258,665 |
| Cost of Goods | 151,267 | 145,823 | 147,069 | 134,811 | 105,478 |
| Gross Profit | 238,725 | 214,248 | 241,578 | 235,421 | 153,187 |
| Operating Expenses | 187,138 | 184,357 | 189,002 | 178,690 | 139,585 |
| Operating Income | 51,854 | 30,714 | 52,645 | 57,542 | 14,080 |
| Interest Expense | 13,149 | 12,929 | 17,351 | 20,796 | 15,682 |
| Other Income | 6,119 | 49,493 | 3,622 | 4,765 | 3,253 |
| Pre-tax Income | 44,824 | 67,278 | 38,916 | 41,511 | 1,651 |
| Income Tax | 9,756 | 21,884 | -53,828 | 9,174 | 2,020 |
| Net Income Continuous | 35,068 | 45,394 | 92,744 | 32,337 | -369 |
| Net Income | $35,068 | $45,394 | $92,744 | $32,337 | $-369 |
| EPS Basic Total Ops | 0.41 | 0.54 | 1.09 | 0.38 | 0.00 |
| EPS Basic Continuous Ops | 0.41 | 0.54 | 1.09 | 0.38 | 0.00 |
| EPS Diluted Total Ops | 0.41 | 0.53 | 1.08 | 0.38 | 0.00 |
| EPS Diluted Continuous Ops | 0.41 | 0.53 | 1.09 | 0.38 | 0.00 |
| EBITDA(a) | $83,456 | $61,649 | $84,740 | $97,812 | $49,311 |